Showing results (261-270 of 516) with videos related to
Sort By:
Pageof 52
The Journal of Experimental Medicine|September 26, 2007
Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout miceTakahisa Murata, Michelle I Lin, Yan Huang, et al.Plos One|February 23, 2012
Endothelium derived nitric oxide synthase negatively regulates the PDGF-survivin pathway during flow-dependent vascular remodelingJun Yu, Yuanyuan Zhang, Xinbo Zhang, et al.Investigational New Drugs|July 1, 1989
A phase II study of spirogermanium in patients with advanced malignant lymphomaC Sessa, W ten Bokkel Huinik, M Clavel, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 23, 2011
Reprinted article "Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): two-year follow-up"F Lurie, D Creton, B Eklof, et al.American Journal of Physiology. Heart and Circulatory Physiology|July 5, 2011
Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanismKanchana Karuppiah, Lawrence J Druhan, Chun-an Chen, et al.Journal Des Maladies Vasculaires|July 10, 1999
[Fate of the competence of the valvular apparatus of the femoral veins after cryopreservation. Preliminary study]B Villemur, I Giardulli, C Sessa, et al.Journal of Vascular Surgery|August 2, 2003
Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study)F Lurie, D Creton, B Eklof, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomasS Leyvraz, M Zweifel, G Jundt, et al.American Journal of Physiology. Heart and Circulatory Physiology|May 11, 2002
Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertensionYasuko Iwakiri, Ming-Hung Tsai, Timothy J McCabe, et al.Cancer Investigation|March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development NetworkD Lacombe, A Butler-Smith, P Therasse, et al.Pageof 52